![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsors and Collaborators: |
University of East Anglia Institute of Food Research Big C Local Cancer Research and Care Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK) |
---|---|
Information provided by: | University of East Anglia |
ClinicalTrials.gov Identifier: | NCT00555386 |
There is evidence to suggest that some dietary components can reduce the risk of breast cancer. In this pilot study two such components, isoflavones (compounds found in soy products) and selenium, will be given to women classed as at moderate to high risk of the disease. The aim is to determine some novel biomarkers of risk and to see the effect of supplementation on them.
Condition | Intervention |
---|---|
Breast Cancer Risk |
Dietary Supplement: Soy and Selenium |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Double Blind (Subject, Investigator), Parallel Assignment |
Official Title: | A Pilot Study to Determine the Effect of Dietary Intervention on Novel Biomarkers of Breast Cancer Risk. |
Enrollment: | 27 |
Study Start Date: | April 2007 |
Study Completion Date: | August 2008 |
Primary Completion Date: | May 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Active Comparator
6g of chocolate (supplemented with selenium and isoflavones) per day for the duration of one menstrual cycle (25-35 days)
|
Dietary Supplement: Soy and Selenium
6g of chocolate per day Control group with no supplementation Active group 50mg of soy protein isolate + 200µg selenium in the form of MSC
|
2: Placebo Comparator
6g of chocolate (control) per day for the duration of one menstrual cycle (25-35 days)
|
Dietary Supplement: Soy and Selenium
6g of chocolate per day Control group with no supplementation Active group 50mg of soy protein isolate + 200µg selenium in the form of MSC
|
The high incidence of breast cancer, its relatively long development phase and the financial burden to the NHS in relation to treatment makes it a prime target for dietary preventative strategies. Epidemiological and experimental investigations suggest several key dietary components that may reduce breast cancer, in particular isoflavones and selenium. Few dietary intervention studies have been conducted to investigate putative protective effects, but with our growing understanding of cancer biology and the application of new -omics technologies it is now possible to use early biomarkers of risk to assess the potential efficacy of intervention studies.
In this pilot project, we will employ a combination of disciplines to examine the effect of dietary intervention in a group of women defined by NICE guidelines as being at increased risk (moderate-high) of developing breast cancer, using metabolomics to assess the tractability of biomarkers in response to the dietary intervention. Such trials are urgently needed to examine the protective effects of diet in women classified at increased risk and who are still in the 'zone of reversibility'. The results of this study will be used to justify and optimise larger scale intervention trials and ultimately to develop appropriate dietary recommendations for the prevention of breast cancer.
A dietary intervention study based on a randomised double-blind parallel design will be conducted in 30 pre-menopausal women (age 35-50) at moderate to high risk of developing breast cancer. The metabolomic profiles of urine and serum samples (collected at baseline and after dietary intervention) will be assessed. Participants will be randomised into two groups; the placebo group (consuming 6g of non-supplemented chocolate per day) and the supplemented group (consuming 6g of chocolate containing both soy and selenium per day). The intervention will last for the duration of one menstrual cycle.
Ages Eligible for Study: | 35 Years to 50 Years |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
United Kingdom, Norfolk | |
University of East Anglia | |
Norwich, Norfolk, United Kingdom, NR47TJ | |
Norfolk and Norwich University Hospital | |
Norwich, Norfolk, United Kingdom, NR4 7UY | |
Institute of Food Research | |
Norwich, Norfolk, United Kingdom, NR4 7UA |
Principal Investigator: | Aedin Cassidy, PhD | University of East Anglia |
Responsible Party: | University of East Anglia ( Professor Aedin Cassidy ) |
Study ID Numbers: | R14697, 07/Q0101/10 |
Study First Received: | November 7, 2007 |
Last Updated: | September 24, 2008 |
ClinicalTrials.gov Identifier: | NCT00555386 |
Health Authority: | United Kingdom: National Health Service; United Kingdom: Research Ethics Committee |
Selenium Soy Breast Cancer Risk |
Selenium Skin Diseases Breast Neoplasms Breast Diseases |
Neoplasms Antioxidants Neoplasms by Site Molecular Mechanisms of Pharmacological Action Growth Substances |
Physiological Effects of Drugs Trace Elements Micronutrients Protective Agents Pharmacologic Actions |